Previous studies reported that the MTG was one of the key brain regions of tau accumulation in aMCI and AD patients (Maass et al., 2017) and showed significant volume reduction during the disease process (Cha et al., 2013; Li K. et al., 2017). This evidence concerns the gene MAPT and Alzheimer disease.